Case Study: a multinational pharmaceutical company improves exposure monitoring with Flare

Multinational Pharmaceutical Company uncovers 1,590 exposure signals with Flare

A multinational pharmaceutical company faced the challenge of gaining a comprehensive view of its exposure on the clear and dark web. Their information security program lacked this holistic visibility, so they reached out to an MSSP who partnered with Flare to conduct an exposure monitoring proof of value.

Using the Flare platform, the MSSP identified and escalated numerous alerts across various risk categories, including intellectual property and leaked credentials. This provided the pharmaceutical company with valuable knowledge of significant risks, leading to a follow-on engagement for an advanced penetration test. The solution by Flare successfully increased the organization's external threat visibility.